Pediatric Cochlear Implant Remote Programming and Assessment
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Nationwide Children's Hospital
- Study ID
- NCT07035873
- Status
- Recruiting
Conditions
- Cochlear Implant Listeners
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 20 Years
- Healthy Volunteers
- Not accepted
Interventions
- Remote Programming — BEHAVIORALUse of the Advanced Bionics Target CI remote programming software to complete behavioral measurements of cochlear implant function and programming via telehealth.
- Remote Speech Perception — DIAGNOSTIC_TESTUse of digital audio streaming (DAS) through a proprietary platform to complete remote speech perception testing of performance with cochlear implants via telehealth.
Study Details
This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measures via iOS mobile application.
Key Dates
- Start date
- Jan 15, 2025
- Status verified
- Apr 2026
- Primary completion
- Jan 15, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Remote Programming & AssessmentRemote cochlear implant programming will be completed via the Advanced Bionics Remote Support iOS application. Remote assessment will be completed using the Advanced Bionics experimental Digital Audio Streaming (DAS) iOS application named EVA.
Primary Outcome Measure
Efficacy and User Satisfaction- Participant [ Time Frame: From enrollment to end of treatment at 6 months ]
Central Contacts
- Ursula M Findlen, PhD614-722-6526
- Nationwide Children's Hospital- Audiology Department614-722-3951
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | Ursula M Findlen, PhD 614-722-6526 |
Find similar trials in Columbus, OH
By research site